Marcus Delatte

Marcus Delatte, PhD, has an extensive work experience history. Marcus started as a Postdoctoral Research Fellow at McLean Hospital/Harvard Medical School in 2004. In 2008, they transitioned to the Food and Drug Administration, where they served as a Senior Pharmacology/Toxicology Reviewer until 2019. From 2019 to 2021, they held roles at Parexel, first as a Principle Consultant and later as Vice President, Technical. Currently, they are the Vice President, Regulatory Strategy at Allucent.

Marcus Delatte, Ph.D. obtained a BA in Psychology from the University of New Orleans in 1999, and went on to earn a Ph.D. in Pharmacology from Louisiana State University Health Sciences Center in 2004.